Download Files:
Dovitinib (lactate hydrate)
SKU
HY-B0062-Get quote
Category Reference compound
Tags c-Kit;FGFR;FLT3;PDGFR;VEGFR, Cancer, Protein Tyrosine Kinase/RTK
Products Details
Product Description
– Dovitinib lactate hydrate (TKI258 lactate hydrate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively[1].
Web ID
– HY-B0062
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C24H29FN6O5
References
– [1]Trudel S, et al. CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. Blood. 2005, 105(7), 2941-2948.
CAS Number
– 915769-50-5
Molecular Weight
– 500.52
SMILES
– O=C1NC2=C(C(F)=CC=C2)C(N)=C1C3=NC4=CC=C(N5CCN(C)CC5)C=C4N3.CC(O)C(O)=O.[H]O[H]
Clinical Information
– Phase 3
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– c-Kit;FGFR;FLT3;PDGFR;VEGFR
Isoform
– FGFR1;FGFR3;PDGFRα;PDGFRβ;VEGFR1/Flt-1;VEGFR2/KDR/Flk-1;VEGFR3/Flt-4
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.